andromeda: daratumumab cybord for al amyloidosis
Published 4 years ago • 349 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
1:50
andromeda: daratumumab & cybord for newly diagnosed al amyloidosis
-
4:30
andromeda: daratumumab for al amyloidosis
-
3:56
andromeda: daratumumab plus vcd in al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
0:54
the potential of daratumumab alone or with cybord in patients with stage iv al amyloidosis
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
3:23
novel agents and clinical trials emerging for the treatment of al amyloidosis
-
2:41
optimizing the use of daratumumab in al amyloidosis
-
1:45:40
what's new and exciting in attr cardiac amyloidosis in 2024
-
6:47
al amyloidosis and a critical, early diagnosis
-
3:10
what is al amyloidosis?
-
0:53
redefining the standard of care in al amyloidosis
-
2:00
andromeda trial: d-vcd versus vcd in the treatment of patients with newly diagnosed al amyloidosis
-
2:03
the role of daratumumab and dara-cybord in newly diagnosed and advanced stage al amyloidosis
-
2:46
single use daratumumab for al amyloidosis
-
1:41
defining the optimal duration of treatment with daracybord & dara maintenance in al amyloidosis
-
1:21
andromeda study: updated safety run-in results
-
1:53
altitude: venetoclax, daratumumab, and dexamethasone in systemic al amyloidosis with t(11;14)
-
2:54
main results from the andromeda study
-
1:42
daratumumab consolidation shows promise in al amyloidosis and light chain deposition disease
-
4:10
updates in al amyloidosis
-
5:14
current status & updates in the management of al amyloidosis